Cargando…
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
The coronavirus (SARS-CoV-2) pandemic is a rapidly transmitting and highly pathogenic disease. The spike protein of SARS-CoV-2 binds to the surface of angiotensin-converting enzyme-2 (ACE2) receptors along the upper respiratory tract and intestinal epithelial cells. SARS-CoV-2 patients develop acute...
Autores principales: | Singh, Desh Deepak, Han, Ihn, Choi, Eun-Ha, Yadav, Dharmendra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677140/ https://www.ncbi.nlm.nih.gov/pubmed/33240881 http://dx.doi.org/10.3389/fcell.2020.580202 |
Ejemplares similares
-
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020) -
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021) -
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
por: Deepak Singh, Desh, et al.
Publicado: (2021) -
SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
por: Singh, Desh Deepak, et al.
Publicado: (2022)